FLUVASTATIN SODIUM

Fluvastatin sodium is an HMG‑CoA reductase inhibitor reducing LDL cholesterol. Side effects include muscle pain, liver enzyme changes, and headache.

SKU: 9321fd36168e Category: Tag:

Product Description


Mechanism of Action

Fluvastatin sodium inhibits HMG‑CoA reductase, reducing cholesterol biosynthesis and increasing LDL receptor expression.

Benefits and Advantages

Used in lipid‑metabolism research, statin‑mechanism modelling and cardiovascular pathway assays.

Side Effects and Risks

Myopathy, elevated liver enzymes and metabolic alterations.

Datasheet


Molecular Formula

C24H25FNNaO4

Molecular Weight

433.4 g/mol

CAS Number

93957-55-2

Storage Condition

Store in a cool, dry place. Keep container tightly closed. Protect from moisture and light.

Solubility

Solubility depends on solvent and conditions (e.g., pH). Please contact us for solvent-specific guidance.

Purity

Purity information is available upon request (COA).

Synonym

FLUVASTATIN SODIUM; 93957-55-2; Fractal; Fluindostatin; Lipaxan

IUPAC/Chemical Name

sodium (E,3S,5R)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoate

InChl Key

ZGGHKIMDNBDHJB-RPQBTBOMSA-M

InChl Code

InChI=1S/C24H26FNO4.Na/c1-15(2)26-21-6-4-3-5-20(21)24(16-7-9-17(25)10-8-16)22(26)12-11-18(27)13-19(28)14-23(29)30;/h3-12,15,18-19,27-28H,13-14H2,1-2H3,(H,29,30);/q;+1/p-1/b12-11+;/t18-,19-;/m0./s1

References

https://pubchem.ncbi.nlm.nih.gov/compound/23679527;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download